species < specific < specifically

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 249.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2006)	Vicente Giner Galva [Espagne] ; María Rosa Oltra [Espagne] ; Diego Rueda [Espagne] ; María José Esteban [Espagne] ; Josep Red N [Espagne]	Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease
000026 (2014)	Avraham Avital [Israël] ; Avigdor Hevroni [Israël] ; Simon Godfrey [Israël] ; Shlomo Cohen [Israël] ; Channa Maayan [Israël] ; Samir Nusair [Israël] ; Lawrence M. Nogee [États-Unis] ; Chaim Springer [Israël]	Natural history of five children with surfactant protein C mutations and interstitial lung disease
000034 (1988)	Robert I. Fox [États-Unis] ; Edward Chan [États-Unis] ; Laurie Benton [États-Unis] ; Sherman Fong [États-Unis] ; Mitchell Friedlaender [États-Unis] ; Francis V. Howell [États-Unis]	Treatment of primary Sjögren's syndrome with hydroxychloroquine
000036 (1995)	Yimin Wei [États-Unis] ; Gloria A. Nygard [États-Unis] ; Shari L. Ellertson [États-Unis] ; Shoukry K. W. Khalil [États-Unis]	Stereoselective disposition of hydroxychloroquine and its metabolites in rats
000059 (1995)	Mark J. Borigini ; Harold E. Paulus	Combination therapy
000088 (2009)	Catherine A. Heyneman [États-Unis]	Systemic Lupus Erythematosus: A Therapeutic Update
000097 (2004)	P. Geraminejad [États-Unis] ; M S Stone [États-Unis] ; R D Sontheimer [États-Unis]	Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus
000100 (2000)	A. Barbato [Italie] ; C. Panizzolo [Italie]	Recent Advances
000104 (1994)	A. Avital [Israël] ; S. Godfrey [Israël] ; C. H. Maayan [Israël] ; Y. Diamant [Israël] ; C. Springer [Israël]	Chloroquine treatment of interstitial lung disease in children
000110 (1978)	D. T. Okpako [Nigeria]	Interactions of aminoquinolines and mepacrine with prostaglandins E2 in tissues of rats and guinea-pigs
000128 (2013)	F. Rongioletti [Italie] ; V. Merlo [Italie] ; S. Riva [Italie] ; E. Cozzani [Italie] ; E. Cinotti [Italie] ; G. Ghigliotti [Italie] ; A. Parodi [Italie] ; J. Kanitakis [France]	Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases
000157 (1992)	Leland L. Fan [États-Unis] ; Ann L. W. Mullen [États-Unis] ; Susan M. Brugman [États-Unis] ; Stephen C. Inscore [États-Unis] ; David P. Parks [États-Unis] ; Carl W. White [États-Unis]	Clinical spectrum of chronic interstitial lung disease in children
000158 (1985)	John M. Young [États-Unis] ; Patrick J. Maloney [États-Unis] ; Shizu N. Jubb [États-Unis] ; Jeffrey S. Clark [États-Unis]	Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse
000207 (2011)	Yvonne E. Chiu [États-Unis] ; Dominic O. Co [États-Unis]	Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis‐Specific Autoantibodies, and Review of Rituximab Use
000221 (1994)	N. Sharief [Royaume-Uni] ; O. F. Crawford [Royaume-Uni] ; R. Dinwiddie [Royaume-Uni]	Fibrosing alveolitis and desquamative interstitial pneumonitis
000228 (2006)	Eugene D. Weinberg [États-Unis]	Therapeutic potential of iron chelators in diseases associated with iron mismanagement
000229 (2008)	Lw Solomon [États-Unis]	Chronic ulcerative stomatitis
000252 (2005)	S. Bernatsky ; M. Hudson ; S. Suissa [Canada]	Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
000256 (2001)	Anthony J. Frew ; Martin J. Plummeridge	Alternative agents in asthma
000278 (2000)	Michael H. Schiff [États-Unis] ; Andrew Whelton [États-Unis]	Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis
000295 (2002)	K. Pavelka [République tchèque] ; Š. Forejtová [République tchèque] ; A. Pavelková [République tchèque] ; J. Zvárová [République tchèque] ; J. Rovensk [République tchèque] ; A. Tuchy Ová [République tchèque]	Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "specific" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "specific" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    specific
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021